Growth Metrics

Zimmer Biomet Holdings (ZBH) Capital Expenditures (2016 - 2026)

Zimmer Biomet Holdings has reported Capital Expenditures over the past 18 years, most recently at $36.3 million for Q1 2026.

  • For Q1 2026, Capital Expenditures fell 18.61% year-over-year to $36.3 million; the TTM value through Mar 2026 reached $216.2 million, up 11.85%, while the annual FY2025 figure was $224.5 million, 10.16% up from the prior year.
  • Capital Expenditures for Q1 2026 was $36.3 million at Zimmer Biomet Holdings, down from $74.8 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $97.3 million in Q2 2023 and troughed at $36.3 million in Q1 2026.
  • A 5-year average of $55.5 million and a median of $51.5 million in 2024 define the central range for Capital Expenditures.
  • Biggest five-year swings in Capital Expenditures: skyrocketed 137.9% in 2023 and later tumbled 47.21% in 2024.
  • Year by year, Capital Expenditures stood at $63.4 million in 2022, then decreased by 0.95% to $62.8 million in 2023, then dropped by 17.99% to $51.5 million in 2024, then surged by 45.24% to $74.8 million in 2025, then tumbled by 51.47% to $36.3 million in 2026.
  • Business Quant data shows Capital Expenditures for ZBH at $36.3 million in Q1 2026, $74.8 million in Q4 2025, and $55.0 million in Q3 2025.